Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

In the past couple of years, payers have come under scrutiny as they increasingly adopt AI tools to automate tasks like the claims review and prior authorization requests. Providers have voiced ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

On Wednesday, the Centers for Medicare & Medicaid Services launched a new initiative in tandem with the White House and HHS aimed at creating a more patient-centric healthcare ecosystem. As part of ...

The FDA turned down an Intercept Pharmaceuticals drug application for the fatty liver disease NASH, a decision that comes nearly three years after the regulator first rejected the molecule. The agency ...

After Congress failed to pass a funding bill, the government shut down early Wednesday morning, which has significant implications for healthcare, including the future of telehealth flexibilities and ...

For healthcare leaders evaluating procurement options or clinicians recommending at-home care, selecting the right gel pack supplier requires careful evaluation of durability, temperature retention, ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...

Eli Lilly’s engineered peptide drugs Mounjaro and Zepbound are once-weekly injectable products, formulations that are expensive to manufacture and burdensome to patients who dislike needles. Lilly ...

A BridgeBio Pharma drug that the company had touted as potentially better than an approved Pfizer product at addressing the protein at the root of a rare heart disorder has instead failed to beat a ...

In a Friday letter, a group of pharmacy organizations called on Congressional leadership to take action on pharmacy benefit manager reform. The organizations included in the letter are the National ...

On April 24, the Centers for Medicare and Medicaid Services announced plans to overhaul the Meaningful Use program by turning to a focus on interoperability. Thus, it only makes sense that the agency ...